Endocrinology · General Practice · 2 h ago
Review highlights gaps in primary hyperparathyroidism diagnosis and care
A debate article in BMC Medicine describes delays in diagnosing primary hyperparathyroidism (PHPT), barriers to parathyroidectomy and gaps in postoperative follow-up. It calls for more consistent diagnostic and referral pathways, while noting that further evidence is needed on disease trajectories and long-term outcomes.
- Diagnostic delays may reflect inconsistent testing and fixed thresholds.
- Referral for surgery may be limited by age or calcium cut-offs.
- The authors call for long-term biochemical and skeletal follow-up.
The BMC Medicine debate article examines gaps across the care continuum for primary hyperparathyroidism (PHPT), a disorder associated with elevated parathyroid hormone and hypercalcaemia. It is not a clinical study and reports no patient sample or new outcome data.
The authors identify inconsistent application of testing guidance, limited use of ionised calcium, vitamin D deficiency that may obscure biochemical findings, and reliance on fixed calcium thresholds as potential contributors to delayed or missed diagnosis. They also describe restrictions on surgical referral based on calcium levels or age, despite evidence they cite that timely parathyroidectomy can improve outcomes across age groups. The article highlights neurocognitive symptoms and other possible systemic manifestations alongside established skeletal and renal complications.
The authors also call for longer-term biochemical monitoring after surgery and structured assessment of skeletal recovery, particularly when disease persists or recurs. They argue for greater clinical awareness and more equitable access to surgery, while acknowledging the need for stronger evidence on disease course, treatment response and follow-up. As a debate article, it offers no new data or formal guideline recommendations.
In practice
For clinicians assessing possible PHPT, the article underscores that reliance on fixed calcium thresholds or overlooking ionised calcium and vitamin D deficiency may contribute to missed or delayed diagnosis. It also highlights referral barriers to parathyroidectomy and the need for biochemical monitoring and assessment of skeletal recovery after surgery. These points are discussed in a debate article, not a new clinical study or formal guideline; it does not provide tested diagnostic algorithms or establish specific follow-up schedules, so it does not by itself justify changing practice.
AI-generated clinical interpretation · Not editor-reviewed
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
BMC Medicine: Primary hyperparathyroidism across the care continuum: gaps in diagnosis, access to surgery, and post-operative care ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.